Search

Your search keyword '"Martinez-Sobrido, Luis"' showing total 826 results

Search Constraints

Start Over You searched for: Author "Martinez-Sobrido, Luis" Remove constraint Author: "Martinez-Sobrido, Luis"
826 results on '"Martinez-Sobrido, Luis"'

Search Results

1. Influenza D virus utilizes both 9-O-acetylated N-acetylneuraminic and 9-O-acetylated N-glycolylneuraminic acids as functional entry receptors.

2. Harnessing preexisting influenza virus-specific immunity increases antibody responses against SARS-CoV-2.

5. Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protective

6. Anti-rheumatic colchicine phytochemical exhibits potent antiviral activities against avian and seasonal Influenza A viruses (IAVs) via targeting different stages of IAV replication cycle

7. Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology.

9. Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects

10. SARS-CoV-2 variants evolve convergent strategies to remodel the host response

11. Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis

12. Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors

13. A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo

14. Author Correction: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

16. SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern

17. A highly efficacious live attenuated mumps virus—based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike

19. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

20. SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming

21. Onward transmission of viruses: how do viruses emerge to cause epidemics after spillover?

25. A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike

26. SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics

27. Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera

28. Modeling SARS-CoV-2 and influenza infections and antiviral treatments in human lung epithelial tissue equivalents

29. Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2

32. Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters

38. Recombinant Influenza A Viruses Expressing Reporter Genes from the Viral NS Segment.

39. Cellular N-Myristoyl Transferases Are Required for Mammarenavirus Multiplication.

40. Valproic acid use is associated with diminished risk of contracting COVID-19, and diminished disease severity: Epidemiologic and in vitro analysis reveal mechanistic insights.

44. SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling

45. Influenza A virus replicates productively in primary human kidney cells and induces factors and mechanisms related to regulated cell death and renal pathology observed in virus-infected patients

46. Influenza D virus utilizes both 9- O -acetylated N -acetylneuraminic and 9- O -acetylated N -glycolylneuraminic acids as functional entry receptors

50. Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets

Catalog

Books, media, physical & digital resources